. Author manuscript; available in PMC: 2020 Feb 1.

Published in final edited form as: Ophthalmology. 2018 Sep 27;126(2):283–295. doi: 10.1016/j.ophtha.2018.08.021

table 2.

Assigned and non-assigned treatments for uveitic macular edema by treatment group.

	Assigned treatment
Number of Eyes with	Periocular (N=74 eyes)	Intravitreal (N=82 eyes)	Dexamethasone (N=79 eyes)
	Assigned Treatments Received^*
1^st injection	73	79	78
2^nd injection	36	38	44
3^rd injection	4	8	3
4^th injection	1	2	0
5^th injection	0	1	0

	Non-Assigned Treatments Received^†
Periocular
1^st injection	n/a	0	4
Intravitreal
1^st injection	24	n/a	0
2^nd injection	3	n/a	0
Dexamethasone
1^st injection	6	6	n/a

All assigned treatments were received according to the protocol schedule except for 2 eyes (1 periocular and 1 intravitreal) that received their second injection at the week 4 visit.

^†

All non-assignment treatment were received after the week 8 assessment (the primary outcome) except for 2 eyes that were assigned to receive periocular injections but received a dexamethasone pellet at the week 4 visit.

N = number; n/a = not applicable.